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Reduced c-Fos expression in orexin neurons of the lateral hypothalamic area and 
the locus coeruleus following injection of spinosin into mice 
Running title: Spinosin reduces c-Fos expression 
 
 
Jian-ping Zhang1, Dan-qiong Liao2, Lin Li3, Lisheng Chu3 
1Department of Anatomy, Histology and Embryology, Basic Medical College, Zhejiang 
Chinese Medical University, Hangzhou, China 
2Clinical Practice Teaching Center, Zhejiang Chinese Medical University, Hangzhou, 
China 
3Department of Physiology, Basic Medical College, Zhejiang Chinese Medical 
University, Hangzhou, China 
 
Address for correspondence: Lisheng Chu, PhD, Department of Physiology, Basic 
Medical, College, Zhejiang Chinese Medical University, Hangzhou 310053, China, tel: 
+86-0571-86613615, e-mail: chulisheng@21cn.com  
 
 
Abstract 
Background: Spinosin, a major component of Semen Zizhiphi Spinosae, has been 
shown to modulate sedation and hypnosis; however, the underlying neuronal 
mechanisms of its stimulatory effects remain unclear.  
Materials and methods: In the present study, we injected spinosin (15 mg/kg) or saline 
into mice, which were killed after 90 min. We isolated the brains, which were 
immunohistochemically stained for c-Fos as a biomarker for neuronal activation and 
assessed the expression profile of c-Fos in various sleep–arousal brain areas.  
Results: Our findings revealed that there were no statistically significant differences in 
the expression of c-Fos in the nucleus accumbens (Acb) and ventrolateral preoptic area 
(VLPO), the vertical limb of the diagonal band (VDB) nucleus, horizontal limb of the 
diagonal band (HDB) nucleus, ventral tuberomammillary (VTM) nucleus, ventral 
tegmental area (VTA), and dorsal raphe (DR) nucleus relative to saline between saline 
and spinosin-treated mice. Unlike saline, spinosin markedly decreased c-Fos expression 
in the lateral hypothalamic area (LHA) as well as the locus coeruleus (LC). Compared 
to the saline injection, the application of spinosin also resulted in a marked decrease in 
c-Fos expression in the LHA orexin neurons.  
Conclusions: These findings suggest that spinosin administration results in a restricted 
pattern of c-Fos expression within the LHA orexin neurons and the LC, suggesting that 
this particular neuronal inactivation contributes to sedation and hypnosis. 
Key words: spinosin, immunohistochemistry, lateral hypothalamic area, locus 
coeruleus, orexin 
 
 
INTRODUCTION 
Zizyphi Spinosi Semen is a traditional tranquilizing medicine that has been 
extensively employed for the treatment of insomnia [1, 2]. Spinosin, which is one of the 
major components of Semen Zizhiphi Spinosae, has been shown to significantly 
potentiate the hypnotic effects of pentobarbital in mice at both 10 and 15 mg/kg by 
decreasing sleep latency, increasing sleep time, and increasing the rate of sleep onset 
induced by a subhypnotic dose of pentobarbital [3]. Spinosin exerted an anxiolytic-like 
effect at 5 mg/kg in the elevated plus maze, light/dark box test, and open field test of 
mice [4]. . In addition, the application of spinosin (15mg/kg) to pentobarbital-treated 
rats significantly induces rapid eye movement (REM) sleep through the postsynaptic 
serotonin 1A(5-HT1A) receptors [5], but whether spinosin-inducing sleep is mediated 
via 5-HT1A receptors remains unclear. Spinosin also induces sleep by disrupting the 
wake-generating systems or by increasing the activity of sleep-promoting systems.  
To identify the neuronal populations and pathways by which spinosin enhances 
sedation and hypnosis, mice were injected with spinosin (15 mg/kg), and then neuronal 
activation patterns in the sleep-arousal brain areas—including the accumbens (Acb) 
nucleus, vertical limb of the diagonal band (VDB) nucleus, horizontal limb of the 
diagonal band (HDB) nucleus, ventrolateral preoptic area (VLPO), lateral hypothalamic 
area (LHA), ventral tuberomammillary (VTM) nucleus, ventral tegmental area (VTA), 
dorsal raphe (DR) nucleus, and locus coeruleus (LC)—were assessed using single c-Fos 
immunohistochemistry followed by dual immunostaining for c-Fos and 
transmitter-specific markers in the neurons of sleep–arousal brain areas based on single 
c-Fos immunohistochemical positive results in the sleep–arousal brain. 
 
 
MATERIALS AND METHODS 
Animals 
Ten pathogen-free adult male mice (Shanghai SLAC Laboratory Animal Co., Ltd., 
China) with weights within the range of 24 to 28 g were maintained in a room with 
conditions of 20°C–22°C and light-regulated conditions (12 h light starting at 0700 h). 
The mice were provided ad libitum access to food and water. The experiment was 
performed after allowing the animals to acclimate to the laboratory conditions for at 
least 1 week. All efforts were made to minimize the number of animals utilized in this 
study and any pain and discomfort experienced by the mice. The protocol for animal 
handling was approved and followed the animal guidelines established by the 
Laboratory Animal Research Center of Zhejiang Chinese Medical University, 
Hangzhou, in Zhejiang province. 
 
Spinosin injection procedures and tissue preparation 
The mice were maintained in cages throughout the entire experiment, except when 
they received spinosin or saline injection. Five mice were injected i.p. with 15 mg/kg of 
spinosin (National Institutes for Food and Drug Control, China; purity: 95.4%) or saline. 
The spinosin doses were selected based on previous studies [3, 5], which consistently 
showed that spinosin administered i.p. at a concentration of 15 mg/kg generated a 
significant increase in sleep time. Spinosin was mixed in a sterile saline solution at a 
dose of 15 mg/mL, and the mice were injected with a volume of 1 mL/kg body weight 
(BW). The injections were administered at 1900 h. After injection, the mice were 
immediately placed back in their cages, and their behavior was monitored every 30 min. 
Approximately 90 min after injection, the mice were subjected to anesthesia using 
chloral hydrate (500 mg/kg, i.p.). Upon confirmation that the mice were unresponsive 
to tail- or foot-pinching, they were perfused with saline and then fixed with 4% 
paraformaldehyde. After perfusion at 4°C for 2 h, their brains were isolated, post-fixed 
overnight in the same fixative, and then transferred to 20% sucrose. Three sets of 
30-μm sections were prepared using a Leica freezing microtome (Leica, type 820-II) at 
the coronal plane, mounted in a cryoprotectant solution, and the stored at −20°C until 
immunohistochemical staining. 
 
Immunohistochemical procedures 
The first set of stored free-floating tissue sections was rinsed in phosphate buffered 
saline (PBS), washed with 3% H2O2 in PBS for 30 min, blocked with 5% goat serum 
(Cat. No. S-1000, Vector Laboratories, Tucson, AZ, USA) and 0.3% Triton X-100 in 
PBS for 1 h at room temperature, and subsequently incubated overnight at 4°C with 
c-Fos polyclonal rabbit antiserum (1:5,000 dilution, Cat. No. PC38, Calbiochem, 
Gibbstown, NJ, USA) for 48 h at 4°C. The tissue sections were then incubated with a 
biotinylated goat anti-rabbit IgG antibody (Vector Laboratories; Cat. No. BA-1000), 
followed by avidin-biotin-horseradish peroxidase complex (ABC) solution (Vectastain 
Elite ABC Kit; Vector Laboratories; Cat. No. PK-4000). The sections were rinsed with 
PBS and then visualized with diaminobenzidine (DAB) in the presence of nickel 
ammonium sulfate, which yielded a black-purple reaction product within the nuclei. 
Then, the sections were rinsed with PBS, placed on gelatin-coated slides, air-dried 
overnight, dehydrated across an ascending alcohol gradient, cleared in xylene, and 
coverslipped. 
The other two batches of sections were processed for double immunofluorescence 
staining for c-Fos and transmitter-specific markers to determine major 
sleep–arousal-promoting neuronal groups. The sections were rinsed with PBS, blocked 
with 5% donkey serum (Cat. No. 017-000-121, Jackson ImmunoResearch Laboratories, 
Inc., West Grove, PA, USA) with 0.3% Triton X-100 in PBS for 1 h at room 
temperature, and then incubated with the primary antiserum for 24 h at 4°C. The 
primary antibodies for transmitter-specific markers consisted of a polyclonal rabbit 
anti-c-Fos (1:5,000, Cat. No. PC38, Calbiochem) and/or a polyclonal goat anti-orexin 
(1:1,000, Cat. No. sc-8070, Santa Cruz Biotechnology, Santa Cruz, CA, USA) to 
identify orexin neurons within the lateral hypothalamic area and a polyclonal rabbit 
anti-c-Fos (1:5000, Cat. No. PC38, Calbiochem)/mouse anti-tyrosine hydroxylase (TH) 
(1:2,000, Cat. No. ab129991, Abcam, Cambridge, UK) to identify dopaminergic 
neurons within the VTA and norepinephrine neurons within the LC. After incubation 
with the primary antiserum, the sections were rinsed with PBS and then incubated with 
a secondary antibody [Alexa Fluor 488-conjugated donkey anti-rabbit IgG (1:1,000, Cat. 
No. A21206, Invitrogen, Carlsbad, CA, USA), Alexa Fluor 594 conjugated-donkey 
anti-goat IgG (1:1,000, Cat. No. 705-585-147, Jackson ImmunoResearch Laboratories, 
Inc., West Grove, PA, USA.), Alexa Fluor 594 conjugated-donkey anti-mouse IgG 
(1:1,000, Cat. No. A21203, Invitrogen)] for 2 h at room temperature. The sections were 
rinsed with PBS, mounted with Fluoromount-G mounting medium (SouthernBiotech, 
Birmingham, AL, USA), and then coverslipped. Negative controls without the primary 
antibody were prepared in all experiments and did not exhibit any immunoreactivity. 
 
Cell counts 
The pattern of c-Fos immunoreactivity within the major brain regions of the 
sleep–arousal system and other brain regions showed significant changes after 
treatment with spinosin. The sections were assessed, and images were captured using an 
Olympus IX71 microscope equipped with fluorescent and bright-field optics. We 
employed Adobe Photoshop CS2 in post-processing the digital photomicrographs as 
well as in preparing the schematic illustrations. Adjustment of sharpness, color balance, 
and contrast was performed to obtain an optimal match of immunohistochemically 
stained cells against the background. The anatomical landmarks and abbreviations 
employed in this study were based on a mouse brain atlas [6]. The outlines of the 
sections and major structures were evaluated at low magnification (4×), followed by 
mapping the profiles of the c-Fos immunoreactive (IR) neurons using high 
magnification. Processing and quantification of c-Fos IR-positive neurons were 
conducted by a treatment-blinded examiner using Image J software (National Institutes 
of Health, Bethesda, MD, USA). Bilateral counts of all nuclei were performed on five 
consecutive sections. The number of c-Fos-stained nuclei and orexin- or TH-stained 
soma was independently counted in tissue sections at representative rostral, middle, as 
well as caudal planes of the lateral hypothalamic area or VTA or LC. The density of the 
c-Fos+orexin(or TH) IR neurons was measured using ImageJ. 
 
Data analysis 
The results of this study are presented as the mean ± standard error of the mean 
(SEM). These ratios are shown as the percentage of the orexin or TH cell populations 
that was doubled-stained for c-Fos. We used the paired t test to detect differences, and 
P-values < 0.05 were deemed statistically significant. 
 
RESULTS 
c-Fos immunoreactivity in major brain areas of the mouse sleep–arousal system 
after injecting spinosin or saline  
The number of cells that were immunopositive for c-Fos was determined in the 
sleep–arousal brain regions, including Acb, VDB, HDB, VLPO, LHA, VTM, VTA, DR, 
as well as LC (Figs. 1 and 2). There were no statistically significant differences in the 
number of c-Fos-IR neurons in the Acb and VLPO and decreases in the number of 
c-Fos-IR in the VDB, HDB, VTM, VTA, and DR between saline and spinosin-injected 
mice (Table 1).  The LHA and LC of saline-treated mice contained a large number of 
c-Fos-IR, while c-Fos expression was markedly decreased in the LHA and LC 
following injection of spinosin into mice (P < 0.01, Table 1). 
 
Spinosin inhibits c-Fos+/orexin+ expression in the LHA  
The orexin neurons within the LHA are generally active when an animal is awake, 
particularly during motor activity as the animal actively explores its immediate 
environment. The noradrenergic cell groups of the LC are major components 
comprising the ascending arousal system. We next aimed to examine the expression of 
c-Fos+/orexin+ in the LHA and c-Fos+/TH+ (noradrenergic neuron marker) in the LC 
following injection of spinosin and saline into mice. Unlike saline, spinosin inhibited 
the expression of c-Fos+/orexin+ in the LHA (Fig. 3). c-Fos+/TH+ expression was not 
observed within the LC (Fig. 4). Paired t test analysis indicated that LHA 
c-Fos+/orexin+ expression was significantly lower after spinosin injection compared to 
saline injection (P < 0.01) (Fig. 5). 
 
DISCUSSION 
Injecting spinosin at a dose of 15 mg/kg did not result in an obvious change in the 
number of c-Fos-IR neurons within the Acb, VDB, HDB, VLPO, VTM, VTA, and DR 
relative to saline injection. Spinosin injection significantly decreased c-Fos expression 
in the LHA and LC. In addition, spinosin also induced a significant decrease in the 
expression of c-Fos in the LHA orexin neurons. This distinct response patterns to 
spinosin suggested that spinosin induces sedation and hypnosis by activating specific 
neuronal populations. 
 
Methodological assessment 
c-Fos immunohistochemistry detects the activation of specific neurons activated in 
response to different experimental conditions; however, this technique is also associated 
with certain limitations. c-Fos expression is induced by an increase in cAMP or calcium 
levels, which commonly occur upon synaptic activation [7].  However, not all activated 
neurons express c-Fos, and cells that are inhibited might not express c-Fos [8, 9]. 
Spinosin may influence neuronal populations that are often overlooked by 
immunohistochemistry. This approach enables the analysis of the correlation between 
neuronal activity and behavioral state, although we were unable to determine whether 
c-Fos expression in the LHA and LC that was inhibited by spinosin was the cause or the 
consequence of sleep. Further investigations on lesions in the LHA and LC in mice may 
further assess whether the LHA and LC neurons are essential to spinosin-induced 
sedation and hypnosis. Here, c-Fos in the Acb, VDB, HDB, and VLPO did not exhibit a 
significant increase in immunoreactivity after spinosin injection, even though these 
regions remain active during sleep. The mechanism underlying the lack of substantial 
increases in c-Fos expression remains unclear, although neuronal discharge patterns and 
the recruitment of certain intracellular signaling pathways could contribute to c-Fos 
induction. The present study employed intraperitoneal injections of spinosin to avoid 
cannula injury, as trauma-induced c-Fos usually occurs within 200 Wm of the cannula 
track [10]. Furthermore, the number of c-Fos-IR nuclei in certain brain areas may vary 
extensively among consecutive sections due to size or shape variations within a cell 
group. Thus, for each brain region, bilateral cell counts using 10 consecutive sections 
were conducted to minimize sampling error. During our visualization of double 
immunostaining of c-Fos and orexin/noradrenergic neurons, we were unable to 
distinguish whether c-Fos expression in a neuron was a direct consequence of spinosin 
in the neurons or an indirect result of the stimulatory effects of spinosin [11].  However, 
the other functions of spinosin did not coincide with the c-Fos expression patterns in 
the LHA and LC. Thus, in the present study, c-Fos expression in LHA orexin neurons 
and LC noradrenergic neurons may be the direct result of spinosin injection or the 
consequence of indirect activation. 
 
c-Fos immunoreactivity patterns induced by spinosin injections 
Acb, which is located within the rostrobasal forebrain, exhibits GABAergic 
projections toward a wide range of targets, such as the ventral pallidum (VP), the LHA, 
the parabrachial nucleus (PB), and the VTA, which may contribute to wakefulness 
[12–14]. VLPO neurons secrete inhibitory neurotransmitters, galanin, and GABA and 
are mainly active during sleep and send efferent projections to various major cell 
groups within the hypothalamus and brainstem that are involved in arousal [15, 16]. The 
VDB and HDB, which are located within the basal forebrain, consist of cholinergic 
neurons, and c-Fos immunoreactivity has been reported during wakefulness but found 
to be significantly lower during sleep [17, 18]. The VTM (histamine neuron), VTA 
(dopamine neuron), DR (serotonin), and LC (noradrenergic neuron) are major 
components of the ascending arousal system participating in cortical arousal [19]. LHA 
orexin neurons form ascending projections toward the cerebral cortex and descending 
projections directed to the monoaminergic and cholinergic cell groups of the arousal 
systems that are highly active during wakefulness [20, 21]. Here, spinosin did not 
induce an obvious change in c-Fos-IR neuron counts in the Acb, VLPO, VDB, HDB, 
VTM, VTA, and DR relative to saline. In addition, spinosin significantly decreased 
c-Fos expression in the LHA orexin neurons and the LC. These results indicate that 
spinosin induces sleep by repressing the wake-generating systems or by enhancing the 
activity of sleep-promoting systems. 
 
How might spinosin induce behavioral sleep? 
The aim of the present study was to determine whether the inhibition of 
arousal-promoting neurons or brain regions is correlated with behavioral sleep after 
spinosin injection. We determined that spinosin markedly downregulated c-Fos in the 
LHA and LC as well as in the LHA orexin neurons. 5-HT1A receptor expression was 
observed in serotonergic neurons as well as in LHA orexin neurons [22, 23]. The 
serotonergic inhibitory signals can hyperpolarize LHA orexin neurons via the 5-HT1A 
receptor, which is involved in the control of sleep–wakefulness states [24].  The 
5-HT1A receptors are also distributed across the LC, with LC noradrenaline (NE) 
metabolism induced via their activation [25, 26]. The 5-HT1A receptor agonist enhanced 
NE metabolism in the LC, which in turn increased the firing rate of this particular brain 
region [27]. An earlier study revealed that spinosin (15 mg/kg, i.g.) significantly 
antagonizes the 5-HT1A agonist 8-OH-DPAT-induced decrease in total sleep time, 
NREM sleep, as well as REM sleep in pentobarbital-treated animals [5]. Furthermore, 
the combined treatment of spinosin and the 5-HT1A antagonist resulted in significant 
augmentative effects on pentobarbital-induced sleep [5]. These findings suggest that 
spinosin could be an antagonist to the postsynaptic 5-HT1A receptors [28]. 
 
CONCLUSIONS 
The results of the present study indicate that spinosin can impart inhibitory effects 
on the firing of the LHA orexin neurons and the LC neurons. This study provides 
important insights into the function of spinosin in regulating sedation and hypnosis. 
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Table 1. Counts of c-Fos-IR neurons in key brain regions of the sleep-arousal system in 
mice following injection of spinosin or saline1. 
Brain region Saline Spinosin 
n 5 5 
Nucleus accumbens 51.39 ± 10.72 57.81 ± 11.43 
Nucleus of the vertical limb of the diagonal 
band 
23.57 ± 4.03 22.43 ± 4.41 
Nucleus of the horizontal limb of the 
diagonal band 
17.21 ± 3.49 16.31 ± 3.30 
Ventrolateral preoptic area 9.51 ± 2.62 9.83 ± 2.14 
Lateral hypothalamic area 133.98 ± 19.53 44.21 ± 9.71* 
Ventral tuberomammillary nucleus 5.04 ± 1.33 3.93 ± 1.15 
Ventral tegmental area 25.41 ± 3.75 23.17 ± 3.49 
Dorsal raphe nucleus 10.04 ± 2.39 8.94 ± 2.05 
Locus coeruleus 91.05 ± 11.49 40.43 ± 5.62* 
1Each value represents a mean±SEM of the number of labeled neurons per section per 
side of the brain that was averaged across animals.“n” indicates the number of animals. 
The difference *P＜0.01 of T-test is compared to saline. 
 
 
Figure 1. Effects of spinosin on key sleep/wake regulatory areas. c-Fos expression in 
Acb, VDB, HDB, and VLPO following injections of spinosin (A, B) or saline (A1, B1). 
Scale bar = 500 μm. 3V, 3rd ventricle; ac, anterior commissural nucleus; Acb, nucleus 
accumbens; HDB, nuclei of the horizontal limb of the diagonal band; LV, lateral 
ventricle; ox, optic chiasm; VDB, nuclei of the vertical limb of the diagonal band; 
VLPO, ventrolateral preoptic area. 
 
Figure 2. Effects of spinosin on key sleep/wake regulatory areas. c-Fos expression in 
LH, VTM, VTA, DR, and LC following injections of spinosin (A, B, C, D) or saline 
(A1, B1, C1, D1). Scale bar = 100 μm in (A, A1) and 500 μm in (B, B1, C, C1, D, D1). 
3V, 3rd ventricle; 4V, 4th ventricle; Aq, aqueduct; DR, dorsal raphe nucleus; f, fornix; 
LC, locus coeruleus; LHA, lateral hypothalamic area; MM, medial mammillary nucleus, 
medial part; VTA, ventral tegmental area; VTM, ventral tuberomammillary nucleus. 
 
Figure 3. Photomicrographs of sections showing dual immunostaining for c-Fos (A, A1, 
green) and orexin (B, B1, red) in the LHA after injecting spinosin (A, B, C, D) or saline 
(A1, B1, C1, D1). Yellow arrowheads show double-labeled cells, and white arrowheads 
show examples of single-labeled orexin cells. Most orexin-IR neurons were positively 
immunostained for c-Fos (A1, B1, C1, D1) after saline injection, but most orexin-IR 
neurons were c-Fos-negative following spinosin injection (A, B, C, D). Scale bar = 200 
μm in (A, A1, B, B1, C, C1) and 100 μm in (D, D1). f, fornix; LHA, lateral 
hypothalamic area. 
 
Figure 4. Photomicrographs of sections showing dual immunostaining for c-Fos (A, A1, 
green) and orexin (B, B1, red) in the LC after injecting spinosin (A, B, C) or saline (A1, 
B1, C1). White arrowheads indicate examples of single-labeled neurons of 
noradrenergic cells. No noradrenergic cells are positive for c-Fos following injections 
of spinosin and saline. Scale bar = 200 μm. 4V, 4th ventricle; LC, locus coeruleus. 
 
Figure 5. Number (mean ± SEM) of dual-labeled c-Fos/orexin-IR in the LHA after 
saline and spinosin injection. LHA, lateral hypothalamic area. Difference from saline: 
*P < 0.01. 





